Voloridge Investment Management
SILK

Voloridge Investment Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Voloridge Investment Management’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-595,827
Closed -$16.1M – 1404
2024
Q2 		$16.1M Buy
+595,827
New +$12.4M 0.06% 442
2023
Q4 		– Sell
-109,737
Closed -$1.64M – 1545
2023
Q3 		$1.64M Buy
+109,737
New +$2.28M 0.01% 977
2021
Q2 		– Sell
-74,845
Closed -$3.79M – 1833
2021
Q1 		$3.79M Buy
74,845
+15,490
+26% +$861K 0.03% 615
2020
Q4 		$3.74M Buy
59,355
+5,014
+9% +$311K 0.03% 528
2020
Q3 		$3.65M Buy
+54,341
New +$2.97M 0.03% 534

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Voloridge Investment Management's SILK Position: Q3 2024 in Review

Voloridge Investment Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 595,827 shares — an estimated $16.1M sold.

Voloridge Investment Management first reported a position in SILK in Q3 2020 and held it in 5 quarters. The position peaked at $16.1M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Voloridge Investment Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 595,827 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $16.1M.
  • Voloridge Investment Management first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Voloridge Investment Management's Silk Road Medical, Inc. Common Stock position peaked at $16.1M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Voloridge Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.